How can the dissemination of double-blind study findings be improved?

Sep 3, 2024 ... This is a randomized, placebo-controlled, double-blind multicenter, phase 2a study assessing the safety, pharmacokinetics (what the body does to ... ... trials. We conducted a randomized, double-blinded, 7 arm clinical trial to: (1) identify the presence of a dose-response for complete protection from emesis ... ... double-blind study of adjuvant pembrolizumab (pembro) with V940 (mRNA-4157) or placebo for renal cell carcinoma (RCC). Based on the phase 3 KEYNOTE-564 trial ... Abstract. In a double-blind trial in 21 patients with spasmodic torticollis botulinum-A toxin produced both subjective and objective improvement, including ... In a double-blind study, neither the patients nor the researchers/doctors know which study group the patients are in. In a triple-blind study, the patients ... Nov 9, 2018 ... A randomized, controlled double-blind study comparing the efficacy and safety of dose-ranging voclosporin with placebo in achieving remission in patients with ... Upon receipt of the test material, researchers will record the date of receipt on their copy of DEA Form 222, or attach the documentation to their retained Copy ... A Phase 2/3, Multicenter, Randomized, Double-Blind Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Oral Ozanimod (RPC1063) ... A randomized, double-blind, multicenter study was conducted to investigate the boosting effect. Havrix in 537 healthy adults 18-53 years of age who had ... In this short-term study, romiplostim increased platelet counts in 88% of children with ITP and was well-tolerated and apparently safe.